Related Experiment Video
Updated: Jul 13, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Cystic bronchiectasis in sarcoidosis.
Raja Shekar Jadav1, Sriharsha Dadana1, Akshay Avula2
1Internal Medicine Cheyenne Regional Medical Center Cheyenne Wyoming USA.
Clinical Case Reports
|October 13, 2023
Summary
Pulmonary sarcoidosis rarely presents with cystic bronchiectasis. This case highlights a rare honeycomb-like pattern in pulmonary sarcoidosis, also involving the heart.
Area of Science:
- Pulmonology
- Radiology
- Cardiology
Background:
- Pulmonary sarcoidosis exhibits diverse radiologic patterns on high-resolution computed tomography (HRCT).
- Typical HRCT findings include bilateral perihilar lymphadenopathy, micronodules, and fibrotic changes.
- Atypical manifestations encompass mass-like opacities, alveolar disease, honeycomb cysts, miliary patterns, tracheobronchial, and pleural involvement.
Observation:
- Cystic bronchiectasis is an exceptionally rare manifestation of pulmonary sarcoidosis.
- This report details a unique case of pulmonary sarcoidosis presenting with cystic bronchiectasis and a honeycomb-like pattern.
- Cardiac involvement was also noted in this patient.
Findings:
- The case demonstrates a rare association between cystic bronchiectasis, a honeycomb-like pattern, and pulmonary sarcoidosis.
- This presentation underscores the wide spectrum of radiologic findings in sarcoidosis.
- The co-occurrence of cardiac involvement adds complexity to the clinical picture.
Implications:
- Recognizing rare radiologic patterns like cystic bronchiectasis is crucial for accurate diagnosis of pulmonary sarcoidosis.
- This case expands the understanding of sarcoidosis manifestations and their potential cardiac sequelae.
- Further research may elucidate the mechanisms behind these rare presentations and inform management strategies.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
256
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
256
Cystic Fibrosis: Management
173
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
173
Pulmonary Tuberculosis II
244
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
244
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
218
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
218
COPD: Pathogenesis and Clinical Features
309
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
309

